View profile

FarmaKology Newsletter - Issue #10

Would you like to submit an article, some interesting news, or get your startup featured? Send whatev


May 7 · Issue #10 · View online
FarmaKology is a newsletter that brings you the latest news, research, job opportunities in the Pharma world, and much more! If you would like to be featured in the newsletter, sponsor an issue, or need anything, please feel free to get in touch with me at "".

Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to “”, and happy to have you featured on our newsletter!

Today's Startup
Avails Medical, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and health-care associated infections. As repeatedly stated by experts around the world, antimicrobial resistance could spell the end of modern medicine.
Once rejected by the FDA, Pfizer’s tafamidis is back and ready to disrupt a rare disease field only recently tapped by Alnylam and Ionis. And the pharma giant’s entrant, now dubbed Vyndaqel, comes with a much lower price tag.
Twelve weeks after filing its supplemental Biologics License Application, Genentech’s Kadcyla secured approval from the U.S. Food and Drug Administration (FDA) for a second breast cancer indication.
Sun Pharmaceutical Industries is scouting for a partner in China to help it win a larger piece of the worlds second-largest drug market, where the government is on a mission to drive down healthcare costs.
Takeda has opening a new research facility in San Diego, CA. The 165,000-square-foot facility is home to more than 250 employees focused on leveraging specialized drug discovery technologies and advancing discovery research in gastroenterology and neuroscience.
Research & Study
396: The Use Of Methylene Blue For The Treatment Of Refractory Anaphylaxis Without Hypotension The Elective Rotation - A Critical Care Pharmacy podcast
Job Opportunities
CelSci updates Phase 3 clinical trial of Advanced Head and Neck Cancer treatment
Did you enjoy this issue?
If you don't want these updates anymore, please unsubscribe here.
If you were forwarded this newsletter and you like it, you can subscribe here.
Powered by Revue